GL1X · GenesisL1 explorer

Research workbench

Crystal structure of putative mandelate RACEMASE/MUCONATE lactonizing protein from clostridium beijerinckii ncimb 8052

Analyse Crystal structure of putative mandelate RACEMASE/MUCONATE lactonizing protein… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3GY1
Type
protein
Length
775 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mandelate RACEMASE/MUCONATE lactonizing protein
UniProt
A6M2W4
Ligands
MG
Pockets
7 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMandelate RACEMASE/MUCONATE lactonizing proteinprotein38741% helix, 20% strandA6M2W4
BMandelate RACEMASE/MUCONATE lactonizing proteinprotein38841% helix, 20% strandA6M2W4

Ligands and binding sites

  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15170.690.7949empty
25110.680.7942empty
33810.670.8035empty
43620.670.8039empty
5640.580.8919empty

Interfaces

1 interface between chains.

  • A–B · 2751 Ų buried · 30 hydrogen bonds · protein-protein

Compared structures

  • 3GY1 · CRYSTAL STRUCTURE OF putative mandelate racemase/muconate lactonizing protein from… · the same entry in another collection · chain A against A, TM-score 1.00
  • A6M2W4 · AlphaFold monomer V2.0 prediction for D-galactonate dehydratase family member CBEI_4837… · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.